Teva Sues Merrill Over ARS Gone Bad
Teva Pharmaceutical Industries Ltd. has initiated litigation alleging that it suffered "staggering losses" after purchasing about $273 million in auction rate securities that were underwritten by Merrill Lynch & Co. Inc....To view the full article, register now.
Already a subscriber? Click here to view full article